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Introduction
The past decade has seen unparalleled
investment in large-scale global health
science initiatives and international re-
search consortia, such as the International
HapMap Project, Grand Challenges in
Global Health program, and International
AIDS Vaccine Initiative. These initiatives
have resulted in promising advances, such
as candidate vaccines for malaria and
HIV, nutritionally enhanced staple crops,
novel vector control strategies, and an
advanced understanding of human genetic
diversity. They have also reflected the
growing emphasis on innovation in global
health and on the urgent need to test
innovations in real-world settings, espe-
cially resource-constrained ones, to deter-
mine their potential effectiveness and
value. Alongside—and necessitated by—
these shifts in global health research, there
has also been a broadening in the
conversation about the ethical aspects of
that research, from an almost singular
focus on standard of care issues [1] to a
more holistic consideration of a wide
range of ethical, social, and cultural
(ESC) influences on the conduct, success,
and impact of biomedical science on
underlying public health problems.
This broadening, in turn, has helped to
fuel a growing interest within the health
research community in consultation ser-
vices in research ethics (CSRE). These are
teams of experts in research ethics,
typically based at academic bioethics
centres, that provide advice and guidance
to researchers and institutions about
ethical issues that arise in the design and
conduct of research. Since first proposed
[2], there has been some attention to the
evolution of CSREs in the literature [3,4],
with much of the focus on how to achieve
an appropriate balance between the advi-
sory/consulting role of the emerging
CSREs and the review, monitoring, and
oversight responsibilities of their counter-
part institutional review boards (IRBs) [5].
Most recently, an article published in
Science Translational Medicine from the Stan-
ford University CSRE has provided im-
portant insights into circumstances that
the authors argue should ‘‘trigger’’ inves-
tigators to seek consultations with the
service [4]. Although the authors point to
‘‘research in developing nations’’ as one
such trigger, there continues to be a gap in
the literature about why and how CSREs
might play an important role in proac-
tively considering and helping to address
the unique ESC challenges posed by
global health research—in particular, re-
search in low- and middle-income coun-
tries (LMICs) that is funded and conduct-
ed, in whole or in part, by organizations
and investigators from high-income coun-
tries—and thereby provide a valuable
complement to customary institutional re-
search ethics review for this type of research.
The purpose of this paper is to encour-
age reflection among the global health
research community, including funders,
researchers, research institutions, and ad-
ministrators of large-scale global health
research initiatives, about how ESC issues
can best be addressed within these initia-
tives. We draw on lessons we have learned
during our experiences with the Ethical,
Social and Cultural Program (ESC Pro-
gram) of the Grand Challenges in Global
Health (GCGH) initiative, funded by the
Bill & Melinda Gates Foundation between
2005–2011 [6], to propose key features of
a focused CSRE, which may prove useful
for those designing or implementing sim-
ilar programs.
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Summary
The purpose of this paper is to
encourage reflection among the
global health research community
and the research ethics community
about how a wide range of ethical,
social, and cultural (ESC) influences
on the conduct, success, and im-
pact of global health research can
best be addressed by consultation
services in research ethics (CSRE).
We draw on lessons we have
learned during our experiences
with the ESC Program of the Grand
Challenges in Global Health initia-
tive to propose key features of CSRE
that may prove useful for those
designing or implementing similar
programs.
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Key Features of an ESC Program
for Global Health Research
1. Integrate ESC Consultation with
the Planning and Performance of
the Research
Integrating science and ethics is funda-
mentally about acknowledging that values
permeate not only trials and applications
of new technologies, but all aspects along
the ‘‘critical path’’ of the scientific pro-
cess—from discovery science through de-
velopment of novel products and technol-
ogies to their effective delivery to end users,
e.g., patients, consumers, communities,
public health authorities—and identifying
where lack of sufficient attention to ESC
issues can undermine the ethics, social
value, quality, feasibility, or sustainability
of the science and its outputs. Effective
integration enables proactive, deeply in-
formed, interdisciplinary thinking, as well
as mutual learning and otherwise unattain-
able insights. Previous ethics programs for
large-scale science initiatives, such as the
Ethical, Legal and Social Implications
(ELSI) Program of the Human Genome
Project, have been criticized for failing to
integrate the ELSI work effectively with the
science [7]. Others, like the US National
Nanotechnology Initiative [8] and Genome
Canada’s GE3LS Program [9], have made
attempts to improve integration through
the mandated formation of multidisciplin-
ary research teams, but the extent to which
these mandates have led to meaningful
integration of ESC considerations remains
unclear.
In designing the ESC Program for the
GCGH, our goal was to prevent ESC
challenges from becoming problems,
where possible, by identifying them much
further upstream than when research
proposals are typically submitted to IRBs
for prospective review, and where preven-
tion was not possible, to help solve them.
Working closely with foundation staff
responsible for R&D program strategy
and funding, in addition to individual
scientists funded through the GCGH
initiative, was a critical element of this
design. Rather than viewing ESC issues
simply as interesting by-products of com-
plex science, such upstream integration
enabled us to better understand how ESC
issues present as specific challenges at
numerous points along the projects’ criti-
cal paths, and how they may be amenable
to ethical analysis and various ESC
solutions or management strategies.
Establishing the necessary working re-
lationships with researchers and founda-
tion staff took time and effort. And we
occasionally had to counter two common
misconceptions about our work: first, that
ESC issues are primarily theoretical and
therefore of limited relevance to the day-
to-day work of successfully conducting
research; and second, that our role was
simply to facilitate the science by clearing
ESC ‘‘bottlenecks’’ for the researchers. We
addressed these concerns by focusing more
of our attention on how R&D program
staff experienced ESC challenges and their
ability to facilitate ESC solutions. We were
initially concerned that our increasing
interactions with R&D program staff
would compromise our objectivity or
contribute to this impression. In fact, this
has rarely been an issue, because we have
been consistent in articulating the impor-
tance and value of our independent
perspective, and also because the ‘‘up-
stream’’ ESC problems tend to be poorly
characterized and therefore less polarized
than some other more well-worn ESC
issues. As well, R&D staff turnover has, in
some situations, required us to ‘‘reset’’
these interactions and is one of the
challenges that can limit the rate of
penetration of the ESC program model.
But despite these challenges, we believe
that intensifying our interactions with the
R&D program staff in particular was
helpful in four main ways: 1. It enabled
identification of ESC issues early in the
critical path of a particular research
initiative; 2. It contributed to a normaliz-
ing of the idea of shared ‘‘ESC thinking,’’
a process we have tried to engender by
regularly engaging program staff in dia-
logue about emerging challenges and what
might count as effective ‘‘solutions’’; 3. It
nurtured a sophisticated expert forum for
‘‘pressure-testing’’ our proposed solutions
to ESC challenges to help ensure they
were feasible, practical, and viable in the
contexts in question; and 4. It helped to
ensure that potentially viable solutions
could be applied to any subsequent
research project within the GCGH pro-
gram, and beyond, in addition to the
immediate value for the particular project
involved in the initial consultation.
2. Privilege Southern Perspectives
Integration of science and ethics gives
prominence to the perspectives of R&D
program staff and researchers—scientists,
social scientists, and humanists alike—in
large-scale research endeavors. In global
health research, there are particularly
complex ethical, social, and cultural di-
mensions to challenges that arise in host
communities that are beyond the knowl-
edge and experience of strictly foreign
ESC teams. To address these challenges
adequately and appropriately it is neces-
sary not only to incorporate the perspec-
tives of local ESC experts, but to privilege
them. Therefore, it is important that an
ESC program seek meaningful contribu-
tions from these essential yet often under-
or unrepresented perspectives, thereby
ensuring that investigators and program
staff have a sufficient depth of understand-
ing and appreciation of the social, eco-
nomic, and political contexts within which
the proposed research will be conducted
[10]. For an ESC program in global health
research, this translates into privileging
perspectives from the ‘‘global South.’’
Despite a great deal of rhetoric to the
contrary, funding programs and individual
research programs and projects aimed at
addressing key health problems of LMICs
continue to arise disproportionately from
elite northern institutions. Although this
state of affairs reflects real and relevant
economic and institutional differences
between high- and LMICs, too little
attention is paid to how LMIC perspec-
tives can be more successfully brought to
bear in the shaping of the agendas and
practices of global health research. It has
also been argued that the conditions
required to support an effective research
ethics ‘‘system’’—to which we would add
more meaningful integration of science
and ethics—are themselves intimately
tied to countries’ level of development
[11].
Nonetheless, strong representation of
Southern perspectives and expertise in
the process of identifying and addressing
ESC challenges in global health research is
critical for: providing cultural guidance,
particularly in situations in which differ-
ences in the meaning of various research
activities can lead to ethically problematic
misunderstandings [12]; leveraging lived
experiences to enhance interpretation of
issues related to relevant LMIC guidelines
and regulations; and more readily and
knowledgeably providing navigation
through complex social and institutional
and regulatory structures in the South as
science moves closer to various forms of
field testing. With this in mind, we
recommend that ESC programs focused
on global health engage bioethicists from
LMICs as co-investigators, staff members,
and post-doctoral fellows.
This is not without its challenges,
however. In our experience, which relies
heavily on each team member to provide
substantive input on specific cases and to
contribute to the broader evolution and
strategic direction of our program, com-
mon challenges related to connecting to
team members working in LMICs—i.e.,
unreliable phone and internet services—
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have often proved debilitating. Similarly,
although the initial design of our program
was to base one of our three primary
programmatic foci at an institution in the
South, those plans were stymied by a
number of administrative hurdles that
stemmed largely from our Northern insti-
tution’s limited experience with interna-
tional partnerships and the lack of readily
accessible ‘‘off-the-shelf’’ models to help
design and guide the development of these
partnerships. The specific challenges faced
in meaningfully engaging essential yet
underrepresented perspectives in other
large-scale research initiatives will depend,
of course, on the particulars of the
initiatives. Nonetheless, we suggest that
due consideration be given to who might/
should bring those perspectives, followed
by planning and feasibility testing of
strategies for engagement prior to imple-
mentation.
3. Build on Specific Cases to Identify
and Propose Solutions to Cross-
Cutting Issues
Our experience has taught us to not
only focus on discrete ESC issues specific
to a particular project or program, but also
to look for opportunities to devise potential
solutions to challenges that cut across
numerous research endeavors. Although
such cross-cutting ‘‘model solutions’’ may
vary significantly in their impact and
ultimate value, they lend themselves well
to strategic dissemination and are thus
useful for stimulating broader dialogue in
the field as well as among leaders and
decision makers looking for concrete
proposals. One path to identifying cross-
cutting issues in need of solutions is to
work upstream in the research process, as
described above, while another is to start
by solving problems at the level of specific
project consultations and extrapolate key
concepts to facilitate development of
broad solutions. Three illustrative exam-
ples of this latter approach from our work
in global health are described below.
Promote respect through effective and ethical
community engagement: There are myriad
examples of how superficial, awkward,
hurried, or otherwise disrespectful forms
of engagement with individuals and com-
munities in LMICs have jeopardized or
prematurely ended global health research
or delivery initiatives [13,14]. And yet,
despite the seemingly obvious significance
of community engagement (CE), current
research ethics guidelines and regulations
have an almost exclusive focus on the
individual and provide very little guidance
about successful interactions with commu-
nities or the underlying rationales for what
respectful engagement of communities
entails [15]. This point has been rein-
forced most recently in the recommenda-
tions of the U.S. Presidential Commission
in its aim to ‘‘further develop operational
guidelines for the protection and ethical
treatment of human subjects through the
means of community engagement’’ [16].
From the outset of our program we have
prioritized the importance of community
engagement (CE), recognizing that the
complex human interactions accompany-
ing the introduction of new global health
technologies—from new contraceptives to
vaccines to TB treatments—can play a
critical role in their impact and sustain-
ability.
Our ability to provide effective integrat-
ed consultation on CE in specific research
projects stems directly from our own
empirical research on CE—funded through
the ESC Program—which generated in-
sights about how CE can contribute to
respectful conduct in research through in-
depth case studies in various research
contexts. For example, our study of CE at
the National Health Research Centre
(NHRC) in northern Ghana revealed how
incorporating traditional community entry
practices into the centre’s approach to CE
helped to promote respectful conduct by
correcting power imbalances between guest
researchers and the host community [17].
As well, our study of the CE strategies
employed in a long-standing prospective
observational cohort study of the genetic
epidemiology of HIV among sex workers in
Nairobi improved our understanding of the
social power of CE practices by demon-
strating how research projects can create
entirely new communities [18].
These insights and experiences from our
empirical research have helped us to
effectively shape a number of cross-cutting
solutions related to CE. For example, our
consultation to help map out ESC consid-
erations for site selection for a caged field
trial of genetically modified mosquitoes
(GMM) for the control of dengue virus
transmission expanded the scope of site
selection criteria to include key regulatory
and CE considerations [19]. These ex-
panded criteria have been referenced in
draft WHO guidance for GMM trials
[20], and a subsequent framework for CE
in GMM trials that arose from the same
collaboration [21] has been cited by the
U.S. Presidential Commission for the
Study of Bioethical Issues [16] and singled
out as a promising general approach in an
editorial in Nature [22].
Fill gaps in regulation, governance,
policies and guidelines: Many ESC
challenges in global health arise from
situations in which regulations, gover-
nance mechanisms, policies, or guidelines
in relevant jurisdictions are either non-
existent or not tailored sufficiently to the
nuances of particular scientific endeavors.
Still other challenges arise when asymme-
tries among various countries’ regulatory
schemes complicate the uniform imple-
mentation of research or delivery activities
within a region. We’ve attempted to meet
these challenges by focusing our efforts on
identifying, critically analyzing, and pro-
posing solutions to fill the regulatory,
governance, and policy gaps encountered
in specific research domains, and then
seeking broader application and impact
for those solutions where feasible and
appropriate. In some instances, the solu-
tions proposed have remained limited to
specific projects (e.g., the development of a
project-specific oversight mechanism for a
project involving stem cell research at
Peking University) [23], while others have
broader implications (e.g., principles for
researchers’ obligations to participants in
observational studies in LMICs, principles
for global health data access) [24,25].
Promote and facilitate responsible
partnerships with the private
sector: The private sector has enor-
mous capacities in manufacturing, pro-
duct development, and supply chain
infrastructure that could prove valuable
in many global health initiatives. But many
private companies have been severely
criticized for unethical practices. As a
result, there is a widespread distrust of the
private sector within many public sector
and civil society organizations, which
results in missed opportunities to leverage
private sector capacities to improve global
health R&D and delivery in certain
circumstances. Driven by the belief that
trust and effective collaboration between
public and private sector partners can be
achieved with the appropriate oversight,
policies, and governance mechanisms, we
have developed several model solutions
focused explicitly on the goal of improving
trust and accountability in public-private
partnerships (PPPs) [26–28]. Our aim has
been to build on experiences with specific
PPPs (e.g., in infant nutrition, agricultural
development) to reduce a vast and
seemingly insurmountable problem into
discrete aspects—e.g., identify and/or
develop useful mechanisms of accoun-
tability, declarations of values, codes of
conduct—that can be applied and evaluated
in a broad set of real world applications.
A standing challenge for the ESC
Program has been balancing our respon-
siveness to demands for ESC consultation
in specific cases with the need to maintain
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an active program of empirical and
conceptual research to help ensure that
the insights and lessons learned through
our consultations can be applied success-
fully to improve our understanding of
cross-cutting ESC issues. This tension
should be anticipated by any new ESC
program and addressed as a key aspect of
the design and funding structure of the
program.
4. Improve the Evaluation of
Strategies, Activities, and Outcomes
The evaluation of the impact of re-
search ethics review and consultation is
grossly underdeveloped [3,4]. As ESC
programs achieve greater integration with
scientific program development and con-
duct, and gain more experience with the
development and dissemination of model
solutions to ESC challenges, it will become
increasingly essential to develop the strat-
egies and means to fairly and thoroughly
evaluate the extent to which ESC prob-
lem-solving can improve the global health
research enterprise. As with many com-
plex programs, however, there are few if
any natural or obvious measures of impact
or effectiveness. Traditional academic
metrics like publications and citations are
generally poor indicators of the real
impact of global health research on, for
example, the health of LMIC populations.
Further complicating the assessment of
ESC programs’ attributable impact on
global health is the fact that their greatest
successes may be in preventing the unde-
sirable—but not inevitable—from occur-
ring.
Through trial and error, we have come
to recognize that meaningful and rigorous
evaluation of the impact of the ESC
Program requires us to look beyond simple
evaluation practices to embrace new
methods for the evaluation of complex
interventions [29]. For example, over the
course of the evolution of the ESC
Program we have progressively shifted
our focus toward improving our ‘‘program
theory’’ of how the ESC Program works;
that is, what are its essential components
and what pathways link them with specific
outcomes? This paper is one product of
this type of analysis. One specific insight
drawn from complex evaluation has been
that our interactions with R&D program
staff, described above, create an ongoing
context for ‘‘co-learning’’ [29], i.e., oppor-
tunities for the ESC Program to gain a
better understanding of how ESC challeng-
es arise and how R&D program staff
understand and manage them, and oppor-
tunities for R&D program staff to contribute
to ESC solutions from the outset and
scrutinize and critique them during their
development. This, in effect, functions as a
built-in evaluation mechanism. We contin-
ue to develop our evaluation practices and
welcome dialogue and collaboration with
other groups who are grappling with these
same challenges.
Conclusions
Research ethics permeates the entirety
of the modern scientific endeavor: institu-
tions and researchers promote and protect
scientific integrity, IRBs protect and pro-
mote the interests of human research
subjects, and CSREs are increasingly
called upon to address ethical issues that
can present perplexing obstacles along the
critical paths to the responsible realization
of scientific and technological advances. In
no domain are scientific advances more
needed than in global health. We hope,
therefore, that in sharing these lessons
above we can help ESC programs focused
on global health to evolve, improve their
practices, and gain prominence. More-
over, the importance of integration, of
looking for broad applications of narrowly
intended solutions, of bringing diverse
perspectives to bear on complex ethical
challenges, and of rigorous impact evalu-
ation are by no means limited to global
health; as such, we hope these lessons may
also prove useful for CSREs focused on a
wide range of scientific endeavors.
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